^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
09/21/2023
Excerpt:
Rectal Cancer: SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE…Adagrasib + panitumumab (KRAS G12C mutation positive)…